I mapped out what OpenAI’s consumer health play could look like for @BusinessInsider:

Tech behemoths like Google, Amazon, and Microsoft have spent decades working to give consumers control of their health data. Many of their efforts have crashed and burned. But industry leaders are betting OpenAI could succeed in healthcare where Big Tech stumbled.

Scoop! OpenAI wants to build its own consumer health apps. The AI giant is considering several consumer health launches, like an AI-powered personal health assistant or a health data aggregator, sources close to the company told me.👇

Starting drama for no reason!

These guidelines help limit OpenAI's liability by telling you to keep a doctor in the loop. They might have implications for OpenAI's healthcare projects down the line. But for now, I doubt the average user will notice any change.

ChatGPT cannot diagnose you or provide in-depth medical advice that's specific to you. It can't say, "you have bronchitis, here's exactly what medication you should take and when." But it CAN say, "here are some remedies for the common cold."

The updated policies say you can't use OpenAI's services for "provision of tailored advice that requires a license, such as legal or medical advice, without appropriate involvement by a licensed professional." Providing general health information does not require a license.

I'm seeing posts that ChatGPT will no longer offer health advice, according to its updated usage policies. That's an oversimplification. OpenAI can still provide answers to health-related questions. It just can't act like your doctor.

My latest:

ICYMI: Perplexity has been fielding investor demand at valuations as high as $50B. The AI search startup most recently raised at a $20B valuation. To some investors, Perplexity's growth warrants the excitement. To others, the offers send a worrying signal of an AI bubble.👇

The market cracked open for healthcare IPOs this year, with debuts from venture-backed startups @HingeHealth and @omadahealth. Zelis’s IPO could set the tone for other PE-backed players waiting on the sidelines. Read the full story here:

Zelis works with 750+ health insurers to simplify payments with providers. It’s now generating nearly $1B in earnings, people familiar with the deal told me.

SCOOP: Healthcare payments platform Zelis has confidentially filed for an IPO. The Bain Capital-backed company has hired Goldman Sachs + JPMorgan for a Q1 2026 debut, sources tell me.

Midi, which offers virtual care for women and is developing an AI search engine for health info, raised a $50M Series C, bringing its total funding to ~$150M (@rebeccatorrenc5 / Business Insider) https://t.co/M4L9Xnp9NO https://t.co/i0hniyEfzc

It’s a story playing out across AI: Microsoft–OpenAI. Google–Anthropic. What happens when an ally and shareholder turns into your biggest competitor? Read in @Business Insider: https://t.co/IBs7GPHcmL (4/4)

Now the two are on a collision course. For Abridge, Epic’s AI plans have created a minefield. Abridge is still reliant on Epic’s unmatched distribution for revenue, but must expand beyond Epic’s reach to secure its future. (3/4)

Epic sells health records software to 42% of US hospitals. The partnership was Abridge’s golden ticket → $700M+ raised, 150+ health system contracts, $5.3B valuation. Earlier this year, Epic sold its Abridge shares, sources told me. (2/4)

Healthcare's hottest startup has a formidable frenemy. AI scribe startup Abridge struck a landmark partnership with medical records giant Epic in 2023. Epic got a single-digit stake in Abridge in the deal, I learned. Now, Epic is gearing up to compete with its own tech. (1/4)

A marvelous weekend profile by BI's @RebeccaTorrenc5 on Riskgaming and @Lpevs's new game Gray Matter. What happens when information, money and attention compete for the future of science and medicine? "Mayhem". All the details and people:

Forward raised $650 million to revolutionize healthcare with its AI. I've been following its collapse all year. Check out the story for all the details!